KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
-0.0700 (-3.85%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close1.8200
Bid1.7600 x 0
Ask1.7800 x 0
Day's Range1.7500 - 1.8500
52 Week Range0.8800 - 4.3500
Avg. Volume483,044
Market Cap187.106M
Beta (3Y Monthly)4.09
PE Ratio (TTM)N/A
EPS (TTM)-0.4360
Earnings DateMay 30, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.58
  • CNW Group

    Khiron Provides Progress Update on Fully Operational and GMP Compliant Colombian Lab Facilities

    State-of-the-art, 14,000 square foot GMP compliant cannabis extraction lab and ISO 17025 compliant cannabis testing lab includes full capabilities in Ultra high and High performance liquid chromatography ...

  • Market Exclusive

    Cannabis Stock News Daily Roundup August 21

    Cannabis provider Liberty Health Sciences (CSE: LHS) (OTCQX: LHSIF) announced the sale of certain of its assets in Florida and substantially all of its assets in Ohio. The company is selling 36 acres of land, comprising its Chestnut Hill Tree Farm site in Alachua County, Florida, as well as all of its assets in Ohio, […]The post Cannabis Stock News Daily Roundup August 21 appeared first on Market Exclusive.

  • How Khiron Life Sciences Corp. (CVE:KHRN) Could Add Value To Your Portfolio
    Simply Wall St.

    How Khiron Life Sciences Corp. (CVE:KHRN) Could Add Value To Your Portfolio

    I've been keeping an eye on Khiron Life Sciences Corp. (CVE:KHRN) because I'm attracted to its fundamentals. Looking...

  • CNW Group

    Khiron Announces DTC Eligibility, Increasing Access for U.S. Investors

    TORONTO, Aug. 20, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that its shares have received Depository Trust Company (DTC) full-service eligibility in the United States. DTC eligibility is expected to simplify the process of trading and transferring of the Company's common shares in the United States.

  • CNW Group

    Khiron Provides Clarification of August 12, 2019 News Release

    TORONTO, Aug. 14, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, wishes to clarify specific disclosure relating to the news release disseminated by the Company on August 12, 2019. Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America. Khiron has core operations in Latin America and is fully licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis.

  • CNW Group

    Khiron Boosts European Expansion With Key Executive Appointments

    Experienced capital markets leader and cannabis industry executive Tejinder Virk is appointed President of Khiron Europe Accomplished cannabis legal expert Franziska Katterbach joins Company as Chief Legal ...

  • CNW Group

    Khiron Launches Revenue-Generating Pilot Program With Top Colombian Health Insurance Provider

    Four-month pilot program with EPS SURA represents first step towards an integrated healthcare system for priority neurological pathologies EPS SURA is Colombia's leading insurance provider and an affiliate ...

  • Baystreet

    Heightened Interest in Hemp-Infused Beauty Products as Large Conglomerates Enter Space

    As the wave of positive reviews roll in, hemp-infused beauty products containing the non-psychoactive ...